Your AI-Trained Oncology Knowledge Connection!
Video
Author(s):
May 2nd 2025 - Jun 7th 2025
May 1st 2025 - Jun 6th 2025
May 1st 2025 - May 2nd 2026
May 9th 2025 - Jun 14th 2025
May 8th 2025 - May 9th 2026
May 2nd 2025 - Jun 7th 2025
May 1st 2025 - Jun 6th 2025
May 1st 2025 - May 2nd 2026
May 9th 2025 - Jun 14th 2025
May 8th 2025 - May 9th 2026
May 2nd 2025 - Jun 7th 2025
May 1st 2025 - Jun 6th 2025
May 1st 2025 - May 2nd 2026
Poll Results Punctuate Key Lung Cancer Abstracts Driving Intrigue Ahead of ASCO 2025
Insights From Liso-cel Combined With Ibr for R/RCLL/SLL: Primary Results From the Open-Label, Phase 1/2 Transcend CLL 004 Study
Overview of the Fixed-Duration Epcoritamab + R-Mini-CHOP in Patients With Previously Untreated DLBCL Ineligible for Full-Dose R-CHOP: Updated Results from Arm 8 of the Epcore NHL-2 Trial
Ultra-Low PSA Response With Darolutamide/ADT Correlates With Better Outcomes in mHSPC
2 Commerce Drive
Cranbury, NJ 08512